Author:
Ismail Zarini,Musa Lailatul Hazzliza,Ithnin Muslimah,Mohamed Nurul Azmawati,Baharom Nizam,Ramli Shalinawati,Pathmanathan Siva Gowri
Abstract
Introduction: Clinical training may expose medical and nursing students to workplace hazards comparable to those encountered by healthcare workers (HCWs). This study was designed to investigate the prevalence of latent tuberculosis infection (LTBI) and associated risk factors among medical and nursing students. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, a systematic review was conducted utilising four electronic databases to appraise and synthesise the literature on LTBI which used the tuberculin skin test (TST) and the blood interferon-gamma release assay (IGRA). Results: Original articles published in the English language between 2010 and 2020 were included, yielding 14 relevant articles. The average prevalence of LTBI in high-burden countries was 38.2% for TST and 20.6% for the IGRA test. According to TST and IGRA findings, the average prevalence of LTBI in nations with an intermediate burden was 16.7% and 4.7 %, respectively. The average prevalence was 2.8% and 1.1% from the TST and IGRA tests for low-burden countries, respectively. A greater risk of LTBI was shown to be related with an increase in age among postgraduate medical school students, a history of Bacillus Calmette-Guerin (BCG) vaccination, origin from high-risk tuberculosis (TB) countries, increased hours of hospital exposure, a history of contact with TB cases, a high body mass index, older age group students, and a lower TB knowledge score. Conclusion: The available evidence from this review emphasised the importance of developing and implementing efficient and cost-effective TB infection-control programmes, particularly in high-burden countries and amongst students at risk.
Publisher
Universiti Putra Malaysia
Reference48 articles.
1. 1. Rojano B, Caminero JA, Hayek M. Curving tuberculosis: current trends and future needs. Ann. Glob. Health 2019; 85(1):5. doi: 10.5334/aogh.2415.
2. 2. World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. [cited 2020 Jul 16]. Available from: https://www.who.int/publications/i/item/9789240013131
3. 3. Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harb. Perspect. Med 2015; 5(2):a017798. doi: 10.1101/cshperspect.a017798
4. 4. Sulis G, Centis R, Sotgiu G, D’Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB. Recent developments in the diagnosis and management of tuberculosis. NPJ Prim Care Respir Med 2016; 26(1):1-8. doi: 10.1038/npjpcrm.2016.78.
5. 5. Drain PK, Gardiner J, Hannah H, Broger T, Dheda K, Fielding K, Walzl G, Kaforou M, Kranzer K, Joosten SA, Gilpin C. Guidance for studies evaluating the accuracy of biomarker-based nonsputum tests to diagnose tuberculosis. J. Infect. Dis 2019; 220(Supplement_3):S108-15. doi: 10.1093/infdis/jiz356.